Differential glycosylation of polymeric and monomeric IgA: A possible role in glomerular inflammation in IgA nephropathy

Journal of the American Society of Nephrology

Volumn 17, Issue 12, 2006, Pages 3529-3539

  Oortwijn, Beatrijs D ^a   Roos, Anja ^a   Royle, Louise ^b   Van Gijlswijk Janssen, Daniëlle J ^a   Faber Krol, Maria C ^a   Eijgenraam, Jan Willem ^a   Dwek, Raymond A ^b   Daha, Mohamed R ^a   Rudd, Pauline M ^b   Van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYTOKINE; IMMUNOGLOBULIN A; INTERLEUKIN 8; LECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLOMERULONEPHRITIS; GLYCOSIDATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEINURIA;

EID: 33845245441     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006040388     Document Type: Article

References (49)

1. Berger J, Hinglais N: Intercapillary deposits of IgA-IgG [in French]. J Urol Nephrol (Paris) 74: 694-695, 1968
2. Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347: 738-748, 2002
3. Tomino Y, Sakai H, Miura M, Endoh M, Nomoto Y: Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol 49: 419-425, 1982
4. Novak J, Julian BA, Tomana M, Mestecky J: Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 21: 310-327, 2001
5. Floege J, Feehally J: IgA nephropathy: Recent developments. J Am Soc Nephrol 11: 2395-2403, 2000
6. van der Boog PJ, van Kooten C, de Fijter JW, Daha MR: Role of macromolecular IgA in IgA nephropathy. Kidney Int 67: 813-821, 2005
7. Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD, Monteiro RC: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 194: 417-425, 2001
8. McDonald KJ, Cameron AJ, Allen JM, Jardine AG: Expression of Fc alpha/mu receptor by human mesangial cells: A candidate receptor for immune complex deposition in IgA nephropathy. Biochem Biophys Res Commun 290: 438-442, 2002
9. van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE, van den Wall Bake AW, Van Es LA, Daha MR: Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int 46: 512-519, 1994
10. Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR: Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17: 1724-1734, 2006
11. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T: Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant 13: 1984-1990, 1998.
12. Roos A, Bouwman LH, Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR: Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167: 2861-2868, 2001
13. Berger J, Yaneva H, Nabarra B, Barbanel C: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7: 232-241, 1975
14. Sanfilippo F, Croker BP, Bollinger RR: Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 33: 370-376, 1982
15. Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V: Increased serum levels of IgA1-IgG immune complexes and anti-F(ab′)2 antibodies in patients with primary IgA nephropathy. Clin Exp Immunol 77: 15-20, 1989
16. van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR: An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. Nephrol Dial Transplant 19: 2487-2493, 2004
17. Oortwijn BD, van der Boog PJ, Roos A, van der Geest RN, de Fijter JW, Daha MR, van Kooten C: A pathogenic role for secretory IgA in IgA nephropathy. Kidney Int 69: 1131-1138, 2006
18. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J: Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 10: 1763-1771, 1999
19. Coppo R, Amore A: Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65: 1544-1547, 2004
20. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81, 1999
21. Mestecky J, Moro B, Underdown BJ: Mucosal immunoglobulins. In: Mucosal Immunology, 2nd ed., edited by Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, San Diego, Academic Press, 1999, pp 133-152
22. Allen AC, Harper SJ, Feehally J: Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100: 470-474, 1995
23. Leung JC, Tang SC, Lam MF, Chan TM, Lai KN: Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int 59: 277-285, 2001
24. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY: Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 136: 168-175, 2004
25. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J: Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 153: 5247-5255, 1994
26. Duque N, Gomez-Guerrero C, Egido J: Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 159: 3474-3482, 1997
27. Leung JC, Tang SC, Chan LY, Tsang AW, Lan HY, Lai KN: Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 18: 36-45, 2003
28. Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M: Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 62: 465-475, 2002
29. de Fijter JW, van den Wall Bake AW, Braam CA, Van Es LA, Daha MR: Immunoglobulin A subclass measurement in serum and saliva: Sensitivity of detection of dimeric IgA2 in ELISA depends on the antibody used. J Immunol Methods 187: 221-232, 1995
30. van Kooten C, Gerritsma JS, Paape ME, Van Es LA, Banchereau J, Daha MR: Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 51: 711-721, 1997
31. Taekema-Roelvink ME, Kooten C, Kooij SV, Heemskerk E, Daha MR: Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 12: 932-940, 2001
32. Royle L, Roos A, Harvey DJ, Wormald MR, Gijlswijk-Janssen D, Redwan E, Wilson IA, Daha MR, Dwek RA, Rudd PM: Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem 278: 20140-20153, 2003
33. Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K: Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem Biophys Res Commun 271: 268-274, 2000
34. Matsuda M, Shikata K, Wada J, Sugimoto H, Shikata Y, Kawasaki T, Makino H: Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron 80: 408-413, 1998
35. Van Es LA, de Fijter JW, Daha MR: Pathogenesis of IgA nephropathy. Nephrology 3: 3-12, 1997
36. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB: Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1: 237-243, 1995
37. Arnold JN, Wormald MR, Suter DM, Radcliffe CM, Harvey DJ, Dwek RA, Rudd PM, Sim RB: Human serum IgM glycosylation: Identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 280: 29080-29087, 2005
38. Julian BA, Novak J: IgA nephropathy: An update. Curr Opin Nephrol Hypertens 13: 171-179, 2004
39. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R: Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 12: 1862-1871, 2001
40. Leung JC, Poon PY, Lai KN: Increased sialylation of polymeric immunoglobulin A1: Mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J Lab Clin Med 133: 152-160, 1999
41. Kabir S: Jacalin: A jackfruit (Artocarpus heterophyllus) seed-derived lectin of versatile applications in immunobiological research. J Immunol Methods 212: 193-211, 1998
42. van der Boog PJ, van Zandbergen G, de Fijter JW, Klar-Mohamad N, van Seggelen A, Brandtzaeg P, Daha MR, van Kooten C: Fc alpha RI/CD89 circulates in human serum covalently linked to IgA in a polymeric state. J Immunol 168: 1252-1258, 2002
43. Delacroix DL, Dive C, Rambaud JC, Vaerman JP: IgA subclasses in various secretions and in serum. Immunology 47: 383-385, 1982
44. Thompson RA, Asquith P, Cooke WT: Secretory IgA in the serum. Lancet 2: 517-519, 1969
45. Delacroix DL, Vaerman JP: A solid phase, direct competition, radioimmunoassay for quantitation of secretory IgA in human serum. J Immunol Methods 40: 345-358, 1981
46. Mole CM, Renoult E, Bene MC, Seilles E, Kessler M, Revillard JP, Faure GC: Serum secretory IgA and IgM and free secretory component in IgA nephropathy. Nephron 71: 75-78, 1995
47. Seilles E, Rossel M, Vuitton DA, Mercier M, Njoya O, Capron JP, Nalpas B, Gibey R, Revillard JP: Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseases. J Hepatol 22: 278-285, 1995
48. Rostoker G, Terzidis H, Petit-Phar M, Meillet D, Lang P, Dubert JM, Lagrue G, Weil B: Secretory IgA are elevated in both saliva and serum of patients with various types of primary glomerulonephritis. Clin Exp Immunol 90: 305-311, 1992
49. de Fijter JW, Eijgenraam JW, Braam CA, Holmgren J, Daha MR, Van Es LA, van den Wall Bake AW: Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 50: 952-961, 1996